Pub Date : 2024-02-07DOI: 10.1177/26324636241226754
S. Paidi, Mounika Chintada
Transcatheter aortic valve replacement (TAVR) has become the mainstream option for patients with symptomatic severe aortic valve stenosis and is preferably performed by the transfemoral route. However, a subset of patients requires alternative access with comorbidities associated with femoral access routes, and alternative access such as transapical, transaxillary, transcarotid, subclavian, and transcaval can be considered. However, access options are further limited by the presence of severe comorbidities. This case reports TAVR performed through a transfemoral approach in a patient with previous aorto bi-iliac bypass graft surgery.
{"title":"Transfemoral TAVR with Surgical Cut-down in a Patient with Aorto Bi-iliac Bypass Graft","authors":"S. Paidi, Mounika Chintada","doi":"10.1177/26324636241226754","DOIUrl":"https://doi.org/10.1177/26324636241226754","url":null,"abstract":"Transcatheter aortic valve replacement (TAVR) has become the mainstream option for patients with symptomatic severe aortic valve stenosis and is preferably performed by the transfemoral route. However, a subset of patients requires alternative access with comorbidities associated with femoral access routes, and alternative access such as transapical, transaxillary, transcarotid, subclavian, and transcaval can be considered. However, access options are further limited by the presence of severe comorbidities. This case reports TAVR performed through a transfemoral approach in a patient with previous aorto bi-iliac bypass graft surgery.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"11 s2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139798027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-07DOI: 10.1177/26324636241226754
S. Paidi, Mounika Chintada
Transcatheter aortic valve replacement (TAVR) has become the mainstream option for patients with symptomatic severe aortic valve stenosis and is preferably performed by the transfemoral route. However, a subset of patients requires alternative access with comorbidities associated with femoral access routes, and alternative access such as transapical, transaxillary, transcarotid, subclavian, and transcaval can be considered. However, access options are further limited by the presence of severe comorbidities. This case reports TAVR performed through a transfemoral approach in a patient with previous aorto bi-iliac bypass graft surgery.
{"title":"Transfemoral TAVR with Surgical Cut-down in a Patient with Aorto Bi-iliac Bypass Graft","authors":"S. Paidi, Mounika Chintada","doi":"10.1177/26324636241226754","DOIUrl":"https://doi.org/10.1177/26324636241226754","url":null,"abstract":"Transcatheter aortic valve replacement (TAVR) has become the mainstream option for patients with symptomatic severe aortic valve stenosis and is preferably performed by the transfemoral route. However, a subset of patients requires alternative access with comorbidities associated with femoral access routes, and alternative access such as transapical, transaxillary, transcarotid, subclavian, and transcaval can be considered. However, access options are further limited by the presence of severe comorbidities. This case reports TAVR performed through a transfemoral approach in a patient with previous aorto bi-iliac bypass graft surgery.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"257 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139857564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-06DOI: 10.1177/26324636241226564
Manoharan Haripriya, N. Sharvani, D. Kishorenaick, Sharan B Singh M, V. Vanajakshamma, V. S. Kiranmayi
Introduction: Oxidative stress plays an indispensable role in the pathogenesis of coronary artery disease (CAD). Several studies suggest that meditation can reduce oxidative stress and improve antioxidant status. This study was designed to evaluate the impact of heartfulness meditation on antioxidant status and lipid profile in patients with coronary artery disease. Methods: Fifty-nine angiographically diagnosed CAD patients were included in the study. Patients who were enrolled practiced heartfulness meditation for a period of six months. Protein thiol (an antioxidant marker), serum total cholesterol (TC), triglycerides (TG), high-density lipoproteins (HDL-C), low-density lipoproteins (LDL-C), and very low-density lipoproteins (VLDL-C) were measured under fasting conditions before and after six months of meditation practice. Results: After six months of practice of heartfulness meditation, there was a statistically significant increase in HDL-C (39.10 ± 8.30 vs. 42.85 ± 8.16, p < .01) and an antioxidant marker protein thiol (257.34 ± 39.68 vs. 345.31 ± 57.53, p < .0001). The mean levels of triglycerides (205.81 ± 88.31 vs. 182.53 ± 93.57 mg dl−1), VLDL-C (41.18 ± 17.64 vs. 36.51 ± 18.71 mg dl−1), and total cholesterol (170.02 ± 40.10 vs. 164.46 ± 42.20 mg dl−1) decreased following the intervention, although the differences were not statistically significant. Conclusion: Heartfulness meditation is an effective means to decrease free radical formation and improve antioxidant status and lipid profile in CAD patients. As a result of this study, regular meditation practice has the potential to be one of the most effective non-pharmacological strategies for CAD prevention.
引言氧化应激在冠状动脉疾病（CAD）的发病机制中扮演着不可或缺的角色。多项研究表明，冥想可以降低氧化应激，改善抗氧化状态。本研究旨在评估静心冥想对冠心病患者抗氧化状态和血脂状况的影响。研究方法59名经血管造影确诊的冠心病患者被纳入研究。参加研究的患者进行了为期六个月的静心冥想。冥想练习前后六个月，在空腹条件下测量蛋白质硫醇（一种抗氧化标记物）、血清总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白（HDL-C）、低密度脂蛋白（LDL-C）和极低密度脂蛋白（VLDL-C）。结果显示经过六个月的静心冥想练习后，高密度脂蛋白胆固醇（HDL-C）（39.10 ± 8.30 vs. 42.85 ± 8.16，p < .01）和抗氧化标志物蛋白硫醇（257.34 ± 39.68 vs. 345.31 ± 57.53，p < .0001）均有统计学意义的显著增加。干预后，甘油三酯（205.81 ± 88.31 vs. 182.53 ± 93.57 mg dl-1）、VLDL-C（41.18 ± 17.64 vs. 36.51 ± 18.71 mg dl-1）和总胆固醇（170.02 ± 40.10 vs. 164.46 ± 42.20 mg dl-1）的平均水平均有所下降，但差异无统计学意义。结论静心冥想是减少自由基形成、改善 CAD 患者抗氧化状态和血脂状况的有效方法。从这项研究的结果来看，定期练习冥想有可能成为预防心血管疾病最有效的非药物疗法之一。
{"title":"Impact of Heartfulness Meditation on Improving Antioxidant Status and Lipid Profile in Patients with Coronary Artery Disease","authors":"Manoharan Haripriya, N. Sharvani, D. Kishorenaick, Sharan B Singh M, V. Vanajakshamma, V. S. Kiranmayi","doi":"10.1177/26324636241226564","DOIUrl":"https://doi.org/10.1177/26324636241226564","url":null,"abstract":"Introduction: Oxidative stress plays an indispensable role in the pathogenesis of coronary artery disease (CAD). Several studies suggest that meditation can reduce oxidative stress and improve antioxidant status. This study was designed to evaluate the impact of heartfulness meditation on antioxidant status and lipid profile in patients with coronary artery disease. Methods: Fifty-nine angiographically diagnosed CAD patients were included in the study. Patients who were enrolled practiced heartfulness meditation for a period of six months. Protein thiol (an antioxidant marker), serum total cholesterol (TC), triglycerides (TG), high-density lipoproteins (HDL-C), low-density lipoproteins (LDL-C), and very low-density lipoproteins (VLDL-C) were measured under fasting conditions before and after six months of meditation practice. Results: After six months of practice of heartfulness meditation, there was a statistically significant increase in HDL-C (39.10 ± 8.30 vs. 42.85 ± 8.16, p < .01) and an antioxidant marker protein thiol (257.34 ± 39.68 vs. 345.31 ± 57.53, p < .0001). The mean levels of triglycerides (205.81 ± 88.31 vs. 182.53 ± 93.57 mg dl−1), VLDL-C (41.18 ± 17.64 vs. 36.51 ± 18.71 mg dl−1), and total cholesterol (170.02 ± 40.10 vs. 164.46 ± 42.20 mg dl−1) decreased following the intervention, although the differences were not statistically significant. Conclusion: Heartfulness meditation is an effective means to decrease free radical formation and improve antioxidant status and lipid profile in CAD patients. As a result of this study, regular meditation practice has the potential to be one of the most effective non-pharmacological strategies for CAD prevention.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"32 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139798826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-06DOI: 10.1177/26324636241227893
Amar N. Patnaik
{"title":"Stellar Performance of members of Telangna State branch of Cardiological Society of India at National Cardiology Meet","authors":"Amar N. Patnaik","doi":"10.1177/26324636241227893","DOIUrl":"https://doi.org/10.1177/26324636241227893","url":null,"abstract":"","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"152 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139859381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-06DOI: 10.1177/26324636241226552
Praveen Nagula, K. Parvathareddy
In this article, the late-breaking trials presented at TCT and AHA 2023 are briefly described. The trials are described under the headings according to the area of interest of the trial.
本文简要介绍了在 TCT 和 AHA 2023 上展示的最新试验。本文将根据试验的关注领域在标题下对试验进行描述。
{"title":"Glimpse of the Trials Presented at TCT and AHA 2023","authors":"Praveen Nagula, K. Parvathareddy","doi":"10.1177/26324636241226552","DOIUrl":"https://doi.org/10.1177/26324636241226552","url":null,"abstract":"In this article, the late-breaking trials presented at TCT and AHA 2023 are briefly described. The trials are described under the headings according to the area of interest of the trial.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"69 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139860880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-06DOI: 10.1177/26324636241226564
Manoharan Haripriya, N. Sharvani, D. Kishorenaick, Sharan B Singh M, V. Vanajakshamma, V. S. Kiranmayi
Introduction: Oxidative stress plays an indispensable role in the pathogenesis of coronary artery disease (CAD). Several studies suggest that meditation can reduce oxidative stress and improve antioxidant status. This study was designed to evaluate the impact of heartfulness meditation on antioxidant status and lipid profile in patients with coronary artery disease. Methods: Fifty-nine angiographically diagnosed CAD patients were included in the study. Patients who were enrolled practiced heartfulness meditation for a period of six months. Protein thiol (an antioxidant marker), serum total cholesterol (TC), triglycerides (TG), high-density lipoproteins (HDL-C), low-density lipoproteins (LDL-C), and very low-density lipoproteins (VLDL-C) were measured under fasting conditions before and after six months of meditation practice. Results: After six months of practice of heartfulness meditation, there was a statistically significant increase in HDL-C (39.10 ± 8.30 vs. 42.85 ± 8.16, p < .01) and an antioxidant marker protein thiol (257.34 ± 39.68 vs. 345.31 ± 57.53, p < .0001). The mean levels of triglycerides (205.81 ± 88.31 vs. 182.53 ± 93.57 mg dl−1), VLDL-C (41.18 ± 17.64 vs. 36.51 ± 18.71 mg dl−1), and total cholesterol (170.02 ± 40.10 vs. 164.46 ± 42.20 mg dl−1) decreased following the intervention, although the differences were not statistically significant. Conclusion: Heartfulness meditation is an effective means to decrease free radical formation and improve antioxidant status and lipid profile in CAD patients. As a result of this study, regular meditation practice has the potential to be one of the most effective non-pharmacological strategies for CAD prevention.
引言氧化应激在冠状动脉疾病（CAD）的发病机制中扮演着不可或缺的角色。多项研究表明，冥想可以减少氧化应激，改善抗氧化状态。本研究旨在评估静心冥想对冠心病患者抗氧化状态和血脂状况的影响。研究方法59名经血管造影确诊的冠心病患者被纳入研究。参加研究的患者进行了为期六个月的静心冥想。冥想练习前后六个月，在空腹条件下测量蛋白质硫醇（一种抗氧化标记物）、血清总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白（HDL-C）、低密度脂蛋白（LDL-C）和极低密度脂蛋白（VLDL-C）。结果显示经过六个月的静心冥想练习后，高密度脂蛋白胆固醇（HDL-C）（39.10 ± 8.30 vs. 42.85 ± 8.16，p < .01）和抗氧化标志物蛋白硫醇（257.34 ± 39.68 vs. 345.31 ± 57.53，p < .0001）均有统计学意义的显著增加。干预后，甘油三酯（205.81 ± 88.31 vs. 182.53 ± 93.57 mg dl-1）、VLDL-C（41.18 ± 17.64 vs. 36.51 ± 18.71 mg dl-1）和总胆固醇（170.02 ± 40.10 vs. 164.46 ± 42.20 mg dl-1）的平均水平均有所下降，但差异无统计学意义。结论静心冥想是减少自由基形成、改善 CAD 患者抗氧化状态和血脂状况的有效方法。从这项研究的结果来看，定期练习冥想有可能成为预防心血管疾病最有效的非药物疗法之一。
{"title":"Impact of Heartfulness Meditation on Improving Antioxidant Status and Lipid Profile in Patients with Coronary Artery Disease","authors":"Manoharan Haripriya, N. Sharvani, D. Kishorenaick, Sharan B Singh M, V. Vanajakshamma, V. S. Kiranmayi","doi":"10.1177/26324636241226564","DOIUrl":"https://doi.org/10.1177/26324636241226564","url":null,"abstract":"Introduction: Oxidative stress plays an indispensable role in the pathogenesis of coronary artery disease (CAD). Several studies suggest that meditation can reduce oxidative stress and improve antioxidant status. This study was designed to evaluate the impact of heartfulness meditation on antioxidant status and lipid profile in patients with coronary artery disease. Methods: Fifty-nine angiographically diagnosed CAD patients were included in the study. Patients who were enrolled practiced heartfulness meditation for a period of six months. Protein thiol (an antioxidant marker), serum total cholesterol (TC), triglycerides (TG), high-density lipoproteins (HDL-C), low-density lipoproteins (LDL-C), and very low-density lipoproteins (VLDL-C) were measured under fasting conditions before and after six months of meditation practice. Results: After six months of practice of heartfulness meditation, there was a statistically significant increase in HDL-C (39.10 ± 8.30 vs. 42.85 ± 8.16, p < .01) and an antioxidant marker protein thiol (257.34 ± 39.68 vs. 345.31 ± 57.53, p < .0001). The mean levels of triglycerides (205.81 ± 88.31 vs. 182.53 ± 93.57 mg dl−1), VLDL-C (41.18 ± 17.64 vs. 36.51 ± 18.71 mg dl−1), and total cholesterol (170.02 ± 40.10 vs. 164.46 ± 42.20 mg dl−1) decreased following the intervention, although the differences were not statistically significant. Conclusion: Heartfulness meditation is an effective means to decrease free radical formation and improve antioxidant status and lipid profile in CAD patients. As a result of this study, regular meditation practice has the potential to be one of the most effective non-pharmacological strategies for CAD prevention.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"153 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139858682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-06DOI: 10.1177/26324636241227893
Amar N. Patnaik
{"title":"Stellar Performance of members of Telangna State branch of Cardiological Society of India at National Cardiology Meet","authors":"Amar N. Patnaik","doi":"10.1177/26324636241227893","DOIUrl":"https://doi.org/10.1177/26324636241227893","url":null,"abstract":"","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"226 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139799597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-06DOI: 10.1177/26324636241226552
Praveen Nagula, K. Parvathareddy
In this article, the late-breaking trials presented at TCT and AHA 2023 are briefly described. The trials are described under the headings according to the area of interest of the trial.
本文简要介绍了在 TCT 和 AHA 2023 上展示的最新试验。本文将根据试验的关注领域在标题下对试验进行描述。
{"title":"Glimpse of the Trials Presented at TCT and AHA 2023","authors":"Praveen Nagula, K. Parvathareddy","doi":"10.1177/26324636241226552","DOIUrl":"https://doi.org/10.1177/26324636241226552","url":null,"abstract":"In this article, the late-breaking trials presented at TCT and AHA 2023 are briefly described. The trials are described under the headings according to the area of interest of the trial.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"100 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139801207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-04DOI: 10.1177/26324636241227024
A. Matthias, Anthony Nilesh Ranjeev Fernandopulle
A 35-year-old patient found to have tuberous xanthomas was diagnosed to have familial hypercholesterolemia (FH). Dermatological manifestations can trigger the diagnosis of FH.
{"title":"Tuberous Xanthoma: A Clue to the Diagnosis of Familial Hypercholesterolemia","authors":"A. Matthias, Anthony Nilesh Ranjeev Fernandopulle","doi":"10.1177/26324636241227024","DOIUrl":"https://doi.org/10.1177/26324636241227024","url":null,"abstract":"A 35-year-old patient found to have tuberous xanthomas was diagnosed to have familial hypercholesterolemia (FH). Dermatological manifestations can trigger the diagnosis of FH.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139806806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-04DOI: 10.1177/26324636231226041
Sudipta Mondal, Dinesh P Raja, Jyothi Vijay
Pacemaker bigeminy is not an uncommon electrocardiographic finding in device clinics. However, such a pattern mandates the differentiation of important possible diagnostic considerations such as premature atrial contractions, oversensing the T wave or the QRS complex, dual AV nodal physiology, and retrograde atrial depolarization. We present a case of pacemaker bigeminy where ventricular pacing was used to exclude the truncated form of pacemaker-mediated tachycardia and reach a diagnosis of atrial bigeminy, which was crucial from the management’s perspective.
{"title":"Ventricular Pacing in Pacemaker Bigeminy to Rule in/out Truncated Pacemaker-mediated Tachycardia","authors":"Sudipta Mondal, Dinesh P Raja, Jyothi Vijay","doi":"10.1177/26324636231226041","DOIUrl":"https://doi.org/10.1177/26324636231226041","url":null,"abstract":"Pacemaker bigeminy is not an uncommon electrocardiographic finding in device clinics. However, such a pattern mandates the differentiation of important possible diagnostic considerations such as premature atrial contractions, oversensing the T wave or the QRS complex, dual AV nodal physiology, and retrograde atrial depolarization. We present a case of pacemaker bigeminy where ventricular pacing was used to exclude the truncated form of pacemaker-mediated tachycardia and reach a diagnosis of atrial bigeminy, which was crucial from the management’s perspective.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"100 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139806855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：